Cargando…
Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients
BACKGROUND: Left ventricular hypertrophy (LVH) has been proved as one among the cardiovascular complications and predominant in patients with CKD. In CKD patients, Glycated albumin (GA) express a superior marker of glycemic control than HbA1c. Nevertheless, the precision of GA for the prediction of...
Autores principales: | Vijayaraghavan, Bhooma, Padmanabhan, Giri, Ramanathan, Kumaresan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750066/ https://www.ncbi.nlm.nih.gov/pubmed/33402919 http://dx.doi.org/10.4314/ahs.v20i1.36 |
Ejemplares similares
-
Circulatory microRNA expression profile for coronary artery calcification in chronic kidney disease patients
por: Vijayaraghavan, Bhooma, et al.
Publicado: (2021) -
Study on Regulation of Low Density Lipoprotein Cholesterol Metabolism using PCSK9 Gene Silencing: A computational Approach
por: Vijayaraghavan, Bhooma, et al.
Publicado: (2018) -
Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications—A systematic review
por: Ramanathan, Kumaresan, et al.
Publicado: (2020) -
Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications
por: Kalaria, Tejaskumar R., et al.
Publicado: (2016) -
Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia
por: Koga, Masafumi, et al.
Publicado: (2010)